Heparanase expression of glioma in human and animal models Laboratory investigation

被引:22
作者
Hong, Xin [1 ]
Nelson, Kevin K. [1 ]
deCarvalho, Ana C. [1 ]
Kalkanis, Steven N. [1 ]
机构
[1] Henry Ford Hlth Syst, Dept Neurosurg, Detroit, MI 48202 USA
关键词
heparanase; glioma; animal model; MATRIX DEGRADATIVE ENZYMES; PRIMARY BREAST-TUMORS; IN-VITRO; MAMMALIAN HEPARANASE; MELANOMA-CELLS; HEPATOCELLULAR-CARCINOMA; CANCER METASTASIS; INHIBITOR PI-88; POOR-PROGNOSIS; PHASE-II;
D O I
10.3171/2009.9.JNS09682
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Object. Mammalian heparanase has been shown to function in tumor progression, invasion, and angiogenesis. However, heparanase expression in gliomas has not been well analyzed. To clarify its expression in gliomas, human glioma tissues and glioma animal models were investigated. Methods. The expression of heparanase mRNA was determined in 33 resected human glioma tissues by semiquantitative real-time polymerase chain reaction. Heparanase expression was verified with a Western blot assay and immunohistochemistry (IHC) staining. Primary neurospheres from human glioblastoma multiforme (GBM) were developed in vitro. Heparanase expression in murine astrocytoma and human primary neurosphere animal models was examined using IHC. Results. The authors found that heparanase naNA is greatly increased in gliomas including oligodendroglioma (9 samples), anaplastic astrocytoma (11 samples), and GBM (13 samples) as compared with healthy brain mRNA (3 samples). Note, however, that no significant difference was observed among the 3 tumor groups. Increased heparanase expression was also found in tumor tissues on Western blotting. Immunohistochemistry staining demonstrated that heparanase was expressed by neovessel endothelial cells, infiltrated neutrophils, and in some cases, by neoplastic cells. Heparanase-expressing cells, including GBM tumor cells and neovessel endothelial cells, exhibited decreased expression of CD44, a cell adhesion molecule on the cell membrane that is important for regulating tumor invasion. In addition, heparanase-expressing tumor cells showed an elevated density of the cell proliferation marker Ki 67, as compared with its density in non heparanase-expressing tumor cells, suggesting that heparanase expression is correlated with enhanced tumor proliferation. Two animal glioma models were tested for heparanase expression. Both murine astrocytoma cells (Ast11.9-2) and cultured primary human GBM neurospheres expressed heparanase when grown in animal brain tissue. Conclusions. Glioma tissues contain increased levels of heparanase. Multiple cell types contribute to the expression of heparanase, including neovessel endothelial cells, tumor cells, and infiltrated neutrophils. Heparanase plays an important role in the control of cell proliferation and invasion. Animal models using Ast11.9-2 and primary neurospheres are suitable for antitumor studies targeting heparanase. (DO!: 10.3171/2009.9.JNS09682)
引用
收藏
页码:261 / 269
页数:9
相关论文
共 55 条
[1]   Heparanase expression at the invasion front of human head and neck cancers and correlation with poor prognosis [J].
Beckhove, P ;
Helmke, BM ;
Ziouta, Y ;
Bucur, M ;
Dörner, W ;
Mogler, C ;
Dyckhoff, G ;
Herold-Mende, C .
CLINICAL CANCER RESEARCH, 2005, 11 (08) :2899-2906
[2]   Microregional extracellular matrix heterogeneity in brain modulates glioma cell invasion [J].
Bellail, AC ;
Hunter, SB ;
Brat, DJ ;
Tan, C ;
Van Meir, EG .
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2004, 36 (06) :1046-1069
[3]   Heparanase induces Akt phosphorylation via a lipid raft receptor [J].
Ben-Zaken, Olga ;
Gingis-Velitski, Svetlana ;
Vlodavsky, Israel ;
Ilan, Neta .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2007, 361 (04) :829-834
[4]  
Bögler O, 1999, CELL GROWTH DIFFER, V10, P73
[5]  
BOGLER O, 1995, CANCER RES, V55, P2746
[6]   Isolation of a human gallbladder cancer cell clone with high invasive phenotype in vitro and metastatic potential in orthotopic model and inhibition of its invasiveness by heparanase antisense oligodeoxynucleotides [J].
Chang, Xin-Zhong ;
Wang, Zhan-Min ;
Yu, Jin-Ming ;
Tian, Fu-Guo ;
Jin, Wei ;
Zhang, Yi ;
Yu, Jie ;
Li, Lian-Fang ;
Liu, Xiao-Feng ;
Li, Zhi-Wei ;
Shao, Zhi-Min .
CLINICAL & EXPERIMENTAL METASTASIS, 2007, 24 (01) :25-38
[7]   Heparanase promotes growth, angiogenesis and survival of primary breast tumors [J].
Cohen, I ;
Pappo, O ;
Elkin, M ;
San, T ;
Bar-Shavit, R ;
Hazan, R ;
Peretz, T ;
Vlodavsky, I ;
Abramovitch, R .
INTERNATIONAL JOURNAL OF CANCER, 2006, 118 (07) :1609-1617
[8]   Heparanase induces VEGF C and facilitates tumor lymphangiogenesis [J].
Cohen-Kaplan, Victoria ;
Naroditsky, Inna ;
Zetser, Anna ;
Illan, Neta ;
Vlodavsky, Israel ;
Doweck, Ilana .
INTERNATIONAL JOURNAL OF CANCER, 2008, 123 (11) :2566-2573
[9]   The role of heparanase in lymph node metastatic dissemination: Dynamic contrast-enhanced MRI of Eb lymphoma in mice [J].
Dafni, H ;
Cohen, B ;
Ziv, K ;
Israely, T ;
Goldshmidt, O ;
Nevo, N ;
Harmelin, A ;
Vlodavsky, I ;
Neeman, M .
NEOPLASIA, 2005, 7 (03) :224-233
[10]   Heparanase gene silencing, tumor invasiveness, angiogenesis, and metastasis [J].
Edovitsky, E ;
Elkin, M ;
Zcharia, E ;
Peretz, T ;
Vlodavsky, I .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2004, 96 (16) :1219-1230